TUCSON, AZ--(Marketwire - Jun 2, 2011) - CDEX Inc. (OTCBB: CEXI), a leading developer of chemical detection products, using patented technologies, for use in healthcare and security markets, announced today that its debenture holders have converted approximately $1.9 million of notes for 22.2 million shares of common stock in the company to support future growth opportunities and market initiatives.